Patents by Inventor Jeffrey Field

Jeffrey Field has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11661186
    Abstract: An unmanned aerial signal relay includes an unmanned aerial vehicle, including a communication relay unit and at least one antenna, communicatively connected to the communication relay unit; a tether comprising at least two wires and at least one fiber optic cable, the wires and cable communicatively connected to the unmanned aerial vehicle; and a surface support system comprising a spool physically connected to the tether and a ground-based receiver communicatively connected to the at least one fiber optic cable, wherein the unmanned aerial vehicle is powered by electrical energy provided by the at least two wires, and wherein the communication relay unit is configured to relay signals received from the at least one antenna via the fiber optic cable to the ground-based receiver. Various systems and methods related to an unmanned aerial signal relay are also described.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: May 30, 2023
    Assignee: Dragonfly Pictures, Inc.
    Inventors: Michael W. Piasecki, Joseph S. Pawelczyk, Jr., Jeffrey Field
  • Publication number: 20230034750
    Abstract: An unmanned aerial signal relay includes an unmanned aerial vehicle, including a communication relay unit and at least one antenna, communicatively connected to the communication relay unit; a tether comprising at least two wires and at least one fiber optic cable, the wires and cable communicatively connected to the unmanned aerial vehicle; and a surface support system comprising a spool physically connected to the tether and a ground-based receiver communicatively connected to the at least one fiber optic cable, wherein the unmanned aerial vehicle is powered by electrical energy provided by the at least two wires, and wherein the communication relay unit is configured to relay signals received from the at least one antenna via the fiber optic cable to the ground-based receiver. Various systems and methods related to an unmanned aerial signal relay are also described.
    Type: Application
    Filed: October 7, 2022
    Publication date: February 2, 2023
    Inventors: Michael W. Piasecki, Joseph S. Pawelczyk, Jr., Jeffrey Field
  • Publication number: 20230034610
    Abstract: An unmanned aerial signal relay includes an unmanned aerial vehicle, including a communication relay unit and at least one antenna, communicatively connected to the communication relay unit; a tether comprising at least two wires and at least one fiber optic cable, the wires and cable communicatively connected to the unmanned aerial vehicle; and a surface support system comprising a spool physically connected to the tether and a ground-based receiver communicatively connected to the at least one fiber optic cable, wherein the unmanned aerial vehicle is powered by electrical energy provided by the at least two wires, and wherein the communication relay unit is configured to relay signals received from the at least one antenna via the fiber optic cable to the ground-based receiver. Various systems and methods related to an unmanned aerial signal relay are also described.
    Type: Application
    Filed: October 7, 2022
    Publication date: February 2, 2023
    Inventors: Michael W. Piasecki, Joseph S. Pawelczyk, JR., Jeffrey Field
  • Publication number: 20220233535
    Abstract: Methods of treating or preventing cancer, or treating or preventing noncancerous tumors or lesions, in a subject in need thereof. The methods involve administering a therapeutically effective amount of one or more inhibitors of the YAP/TAZ pathway to the subject. In addition, methods of inhibiting or preventing glycolysis in cancer cells in a subject, promoting mitochondrial respiration in cancer cells in a subject, and promoting oxidative stress in cancer cells in a subject, by administering a therapeutically effective amount of one or more inhibitors of the YAP/TAZ pathway to the subject.
    Type: Application
    Filed: April 26, 2020
    Publication date: July 28, 2022
    Inventors: Chunling Yi, Shannon M. White, Jeffrey Field
  • Publication number: 20200385115
    Abstract: An unmanned aerial signal relay includes an unmanned aerial vehicle, including a communication relay unit and at least one antenna, communicatively connected to the communication relay unit; a tether comprising at least two wires and at least one fiber optic cable, the wires and cable communicatively connected to the unmanned aerial vehicle; and a surface support system comprising a spool physically connected to the tether and a ground-based receiver communicatively connected to the at least one fiber optic cable, wherein the unmanned aerial vehicle is powered by electrical energy provided by the at least two wires, and wherein the communication relay unit is configured to relay signals received from the at least one antenna via the fiber optic cable to the ground-based receiver. Various systems and methods related to an unmanned aerial signal relay are also described.
    Type: Application
    Filed: June 10, 2019
    Publication date: December 10, 2020
    Inventors: Michael W. Piasecki, Joseph S. Pawelczyk, JR., Jeffrey Field
  • Patent number: 9987203
    Abstract: A method of improving the cosmetic appearance of human teeth comprising the step of contacting the teeth with a whitening powder composition after ingesting a chromogenic, tannin-containing food or beverage and thereby reducing staining of the teeth caused by tannins and/or chromogens. The tooth-whitening tablet is comprised of (i) at least one abrasive powder; (ii) at least one buffering powder; (iii) a complexing agent; and, optionally, (iv) an anti-cavity sweetener.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: June 5, 2018
    Assignee: Unwined, Inc
    Inventors: Jeffrey A. Field, Dennis L. Lott
  • Publication number: 20130126571
    Abstract: A bag for carrying and storing an umbrella includes an elongated, tubular sleeve portion with an open end and a closed end defining an interior sized to accommodate the umbrella. The opened end can receive the umbrella lengthwise into the interior. Attached to the closed end can be an end cap having a central drainage aperture disposed therethrough. The drainage aperture can sealingly engage with an elongated tip on the umbrella to retain moisture from the umbrella within the interior of the bag. The umbrella tip can be selectively removed from and inserted into the drainage aperture to selectively seal and unseal the drainage aperture. In some embodiments, a sealing gasket can be disposed in the end cap to facilitate sealing of the drainage aperture.
    Type: Application
    Filed: May 18, 2012
    Publication date: May 23, 2013
    Inventor: Jeffrey FIELD
  • Patent number: 8398586
    Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: March 19, 2013
    Assignee: Applied Diabetes Research Incorporated
    Inventors: George R. Lynch, Allen E. Brandenburg, Jeffrey Field, Monte Curran, Andrew Nelson
  • Publication number: 20100324487
    Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 23, 2010
    Inventors: George R. Lynch, Allen E. Brandenburg, Jeffrey Field, Monte Curran, Andrew Nelson
  • Patent number: 7766867
    Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.
    Type: Grant
    Filed: March 21, 2007
    Date of Patent: August 3, 2010
    Assignee: Applied Diabetes Research, Inc.
    Inventors: George R. Lynch, Allen E. Brandenburg, Jeffrey Field, Monte Curran, Andrew Nelson
  • Patent number: 7641637
    Abstract: A controlled volume injection/aspiration device includes a syringe having a body for containing a medicament, a needle and a piston slidably disposed within the body. A shell is provided for receiving the syringe body and a plunger rack is disposed within the shell. A manually operated control is disposed in an operative relationship with the plunger rack for moving the plunger rack in a stepwise forward direction causing the piston to eject discrete doses of medication from the syringe body through the needle. The manual operated control is also operative for moving the piston in a stepwise reverse direction causing the piston to aspirate fluid into the syringe body through the needle.
    Type: Grant
    Filed: April 23, 2008
    Date of Patent: January 5, 2010
    Assignee: Allergan, Inc
    Inventors: Scott J. Gerondale, Steven D. Kimmell, Jeffrey Field
  • Publication number: 20080200882
    Abstract: A controlled volume injection/aspiration device includes a syringe having a body for containing a medicament, a needle and a piston slidably disposed within the body. A shell is provided for receiving the syringe body and a plunger rack is disposed within the shell. A manually operated control is disposed in an operative relationship with the plunger rack for moving the plunger rack in a stepwise forward direction causing the piston to eject discrete doses of medication from the syringe body through the needle. The manual operated control is also operative for moving the piston in a stepwise reverse direction causing the piston to aspirate fluid into the syringe body through the needle.
    Type: Application
    Filed: April 23, 2008
    Publication date: August 21, 2008
    Inventors: SCOTT J. GERONDALE, Steven D. Kimmell, Jeffrey Field
  • Patent number: 7364570
    Abstract: A controlled volume injection/aspiration device includes a syringe having a body for containing a medicament, a needle and a piston slidably disposed within the body. A shell is provided for receiving the syringe body and a plunger rack is disposed within the shell. A manually operated control is disposed in an operative relationship with the plunger rack for moving the plunger rack in a stepwise forward direction causing the piston to eject discrete doses of medication from the syringe body through the needle. The manual operated control is also operative for moving the piston in a stepwise reverse direction causing the piston to aspirate fluid into the syringe body through the needle.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: April 29, 2008
    Assignee: Allergan, Inc.
    Inventors: Scott J. Gerondale, Steven D. Kimmell, Jeffrey Field
  • Publication number: 20070173767
    Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.
    Type: Application
    Filed: March 21, 2007
    Publication date: July 26, 2007
    Inventors: George Lynch, Allen Brandenburg, Jeffrey Field, Monte Curran, Andrew Nelson
  • Publication number: 20070156094
    Abstract: An insertion device and insertion set. The insertion device for inserting at least a portion of at least one piercing member of an insertion set through the skin of a patient includes a device housing, a carrier body and a driver. The carrier body is slidably received within the device housing for movement between an advanced position and a retracted position. The carrier body also includes a receiving structure to support the insertion set in a position with the at least one piercing member oriented for insertion through the skin of the patient at a predetermined angle relative to the skin of the patient upon movement of the carrier body from the retracted position to the advanced position.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 5, 2007
    Inventors: Jason Safabash, Susan McConnell, Randy Adair, Jeffery Funderburk, April Marano, Jeffrey Field
  • Patent number: 7214207
    Abstract: This invention relates to therapeutic infusion assemblies, more specifically a device for the subcutaneous delivery of a fluid from a remote source. Applicant provides a base assembly which has a fluid channel therein and a cannula extending vertically downward from a flat bottom. A fluid connector member which receives a fluid bearing line from the remote fluid source and the fluid connector member pivotably and removably connects to the base member. The manner of connection is “hinged” allowing the fluid connector to move from a non-use position by rotation downward to a used position. In the use position a fluid channel in the fluid connector will connect with a fluid channel in the base to provide fluid to the cannula and to the patient.
    Type: Grant
    Filed: March 7, 2003
    Date of Patent: May 8, 2007
    Assignee: Applied Diabetes Research, Inc.
    Inventors: George R. Lynch, Allen E. Brandenburg, Jeffrey Field, Monte Curran, Andrew Nelson
  • Publication number: 20060229560
    Abstract: A system for delivery of therapeutic and/or diagnostic agents into a living body includes a port assembly having a cannula extending from the mounting side, a port opening away from the mounting side and a resilient barrier between the port and the cannula. An access hub includes a connector positionable at the port for opening the resilient barrier. The access hub is movable in the port assembly, is engaged therewith through a resilient ring coupling and forms a seal with the resilient barrier, reducing the amount of volume to be primed. Inserters, both disposable and reusable, include the cannula insertion member as part of the assembly. A spring loaded port driver is operatively mounted within the housing with movement controlled by a latch. The driver includes a seat for receipt of a port assembly. The cannula insertion member is nonremovably fixed in a socket in the port driver in the disposable assembly.
    Type: Application
    Filed: June 8, 2006
    Publication date: October 12, 2006
    Inventors: April Marano-Ford, Susan McConnell-Montalvo, Jeffrey Field
  • Publication number: 20060229559
    Abstract: A system for delivery of therapeutic and/or diagnostic agents into a living body includes a port assembly having a cannula extending from the mounting side, a port opening away from the mounting side and a resilient barrier between the port and the cannula. An access hub includes a connector positionable at the port for opening the resilient barrier. The access hub is movable in the port assembly, is engaged therewith through a resilient ring coupling and forms a seal with the resilient barrier, reducing the amount of volume to be primed. Inserters, both disposable and reusable, include the cannula insertion member as part of the assembly. A spring loaded port driver is operatively mounted within the housing with movement controlled by a latch. The driver includes a seat for receipt of a port assembly. The cannula insertion member is nonremovably fixed in a socket in the port driver in the disposable assembly.
    Type: Application
    Filed: June 8, 2006
    Publication date: October 12, 2006
    Inventors: April Marano-Ford, Susan McConnell-Montalvo, Jeffrey Field
  • Publication number: 20060095003
    Abstract: A system for delivery of therapeutic and/or diagnostic agents into a living body includes a port assembly having a cannula extending from the mounting side, a port opening away from the mounting side and a resilient barrier between. the port and the cannula. An access hub includes a connector positionable at the port for opening the resilient barrier. The access hub is movable in the port assembly, is engaged therewith through a resilient ring coupling and forms a seal with the resilient barrier, reducing the amount of volume to be primed. Inserters, both disposable and reusable, include the cannula insertion member as part of the assembly. A spring loaded port driver is operatively mounted within the housing with movement controlled by a latch. The driver includes a seat for receipt of a port assembly. The cannula insertion member is nonremovably fixed in a socket in the port driver in the disposable assembly.
    Type: Application
    Filed: December 13, 2005
    Publication date: May 4, 2006
    Inventors: April Marano-Ford, Susan McConnell-Montalvo, Jeffrey Field
  • Publication number: 20060069351
    Abstract: An insertion device and insertion set. The insertion device for inserting at least a portion of at least one piercing member of an insertion set through the skin of a patient includes a device housing, a carrier body and a driver. The carrier body is slidably received within the device housing for movement between an advanced position and a retracted position. The carrier body also includes a receiving structure to support the insertion set in a position with the at least one piercing member oriented for insertion through the skin of the patient at a predetermined angle relative to the skin of the patient upon movement of the carrier body from the retracted position to the advanced position.
    Type: Application
    Filed: February 21, 2003
    Publication date: March 30, 2006
    Inventors: Jason Safabash, Susan McConnell, Randy Adair, Jeffery Funderburk, April Marano, Jeffrey Field